These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23760677)

  • 1. A history of previous gestational diabetes mellitus is associated with adverse changes in insulin secretion and VLDL metabolism independently of increased intrahepatocellular lipid.
    Forbes S; Godsland IF; Taylor-Robinson SD; Bell JD; Thomas EL; Patel N; Hamilton G; Parker KH; Marshall I; Gray CD; Bedford D; Caslake M; Walker BR; Johnston DG
    Diabetologia; 2013 Sep; 56(9):2021-33. PubMed ID: 23760677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrahepatic insulin exposure, intrahepatocellular lipid and regional body fat in nonalcoholic fatty liver disease.
    Mehta SR; Godsland IF; Thomas EL; Pavitt DV; Morin SX; Bell JD; Taylor-Robinson SD; Johnston DG
    J Clin Endocrinol Metab; 2012 Jun; 97(6):2151-9. PubMed ID: 22442265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body and liver fat mass rather than muscle mitochondrial function determine glucose metabolism in women with a history of gestational diabetes mellitus.
    Prikoszovich T; Winzer C; Schmid AI; Szendroedi J; Chmelik M; Pacini G; Krssák M; Moser E; Funahashi T; Waldhäusl W; Kautzky-Willer A; Roden M
    Diabetes Care; 2011 Feb; 34(2):430-6. PubMed ID: 20978097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise Training Reduces Liver Fat and Increases Rates of VLDL Clearance But Not VLDL Production in NAFLD.
    Shojaee-Moradie F; Cuthbertson DJ; Barrett M; Jackson NC; Herring R; Thomas EL; Bell J; Kemp GJ; Wright J; Umpleby AM
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4219-4228. PubMed ID: 27583475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effect of non-alcoholic fatty liver disease and history of gestational diabetes to increase risk of type 2 diabetes.
    Cho Y; Chang Y; Ryu S; Wild SH; Byrne CD
    Eur J Epidemiol; 2023 Aug; 38(8):901-911. PubMed ID: 37253998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic Fatty Liver Disease Is Prevalent in Women With Prior Gestational Diabetes Mellitus and Independently Associated With Insulin Resistance and Waist Circumference.
    Foghsgaard S; Andreasen C; Vedtofte L; Andersen ES; Bahne E; Strandberg C; Buhl T; Holst JJ; Svare JA; Clausen TD; Mathiesen ER; Damm P; Gluud LL; Knop FK; Vilsbøll T
    Diabetes Care; 2017 Jan; 40(1):109-116. PubMed ID: 27810989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired Insulin Suppression of VLDL-Triglyceride Kinetics in Nonalcoholic Fatty Liver Disease.
    Poulsen MK; Nellemann B; Stødkilde-Jørgensen H; Pedersen SB; Grønbæk H; Nielsen S
    J Clin Endocrinol Metab; 2016 Apr; 101(4):1637-46. PubMed ID: 26829441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. History of Gestational Diabetes and Incident Nonalcoholic Fatty Liver Disease: The Kangbuk Samsung Health Study.
    Cho Y; Chang Y; Ryu S; Kim C; Wild SH; Byrne CD
    Am J Gastroenterol; 2023 Nov; 118(11):1980-1988. PubMed ID: 36940424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity.
    Riches FM; Watts GF; Naoumova RP; Kelly JM; Croft KD; Thompson GR
    Int J Obes Relat Metab Disord; 1998 May; 22(5):414-23. PubMed ID: 9622338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased prevalence of non-alcoholic fatty liver disease in European women with a history of gestational diabetes.
    Forbes S; Taylor-Robinson SD; Patel N; Allan P; Walker BR; Johnston DG
    Diabetologia; 2011 Mar; 54(3):641-7. PubMed ID: 21153530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease.
    Fabbrini E; Mohammed BS; Magkos F; Korenblat KM; Patterson BW; Klein S
    Gastroenterology; 2008 Feb; 134(2):424-31. PubMed ID: 18242210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gestational diabetes mellitus worsens the profile of cardiometabolic risk markers and decrease indexes of beta-cell function independently of insulin resistance in nondiabetic women with a parental history of type 2 diabetes.
    Sokup A; Ruszkowska-Ciastek B; Walentowicz-Sadłecka M; Grabiec M; Rość D
    J Diabetes Res; 2014; 2014():743495. PubMed ID: 25097861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ectopic lipid storage in non-alcoholic fatty liver disease is not mediated by impaired mitochondrial oxidative capacity in skeletal muscle.
    Cuthbertson DJ; Irwin A; Sprung VS; Jones H; Pugh CJ; Daousi C; Adams VL; Bimson WE; Shojaee-Moradie F; Richardson P; Umpleby AM; Wilding JP; Kemp GJ
    Clin Sci (Lond); 2014 Dec; 127(12):655-63. PubMed ID: 24738611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproducibility of glucose, fatty acid and VLDL kinetics and multi-organ insulin sensitivity in obese subjects with non-alcoholic fatty liver disease.
    Magkos F; Fabbrini E; Korenblat K; Okunade AL; Patterson BW; Klein S
    Int J Obes (Lond); 2011 Sep; 35(9):1233-40. PubMed ID: 21179000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysfunction of estrogen-related receptor alpha-dependent hepatic VLDL secretion contributes to sex disparity in NAFLD/NASH development.
    Yang M; Liu Q; Huang T; Tan W; Qu L; Chen T; Pan H; Chen L; Liu J; Wong CW; Lu WW; Guan M
    Theranostics; 2020; 10(24):10874-10891. PubMed ID: 33042259
    [No Abstract]   [Full Text] [Related]  

  • 16. No effect of resveratrol on VLDL-TG kinetics and insulin sensitivity in obese men with nonalcoholic fatty liver disease.
    Poulsen MK; Nellemann B; Bibby BM; Stødkilde-Jørgensen H; Pedersen SB; Grønbaek H; Nielsen S
    Diabetes Obes Metab; 2018 Oct; 20(10):2504-2509. PubMed ID: 29885082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overproduction of large VLDL particles is driven by increased liver fat content in man.
    Adiels M; Taskinen MR; Packard C; Caslake MJ; Soro-Paavonen A; Westerbacka J; Vehkavaara S; Häkkinen A; Olofsson SO; Yki-Järvinen H; Borén J
    Diabetologia; 2006 Apr; 49(4):755-65. PubMed ID: 16463046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased intramyocellular lipid concentration identifies impaired glucose metabolism in women with previous gestational diabetes.
    Kautzky-Willer A; Krssak M; Winzer C; Pacini G; Tura A; Farhan S; Wagner O; Brabant G; Horn R; Stingl H; Schneider B; Waldhäusl W; Roden M
    Diabetes; 2003 Feb; 52(2):244-51. PubMed ID: 12540593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of apolipoprotein B dyslipoproteinemias in non-alcoholic fatty liver disease: The lifelines cohort study.
    Nass KJ; van den Berg EH; Faber KN; Schreuder TCMA; Blokzijl H; Dullaart RPF
    Metabolism; 2017 Jul; 72():37-46. PubMed ID: 28641782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-alcoholic fatty liver disease in the first trimester and subsequent development of gestational diabetes mellitus.
    Lee SM; Kwak SH; Koo JN; Oh IH; Kwon JE; Kim BJ; Kim SM; Kim SY; Kim GM; Joo SK; Koo BK; Shin S; Vixay C; Norwitz ER; Park CW; Jun JK; Kim W; Park JS
    Diabetologia; 2019 Feb; 62(2):238-248. PubMed ID: 30470912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.